Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Marizyme Inc. MRZM

Marizyme is a multi-technology biomedical company dedicated to the accelerated development & commercialization of medical device technologies that improve patient health outcomes. Marizyme seeks to leverage their healthcare innovations biomedical technologies: DuraGraft®, Krillase®, & MATLOCTM to address critical market gaps & offer transformative potential to wide range of issues including coronary artery bypass graft (CABG) surgery, fat grafting, pet health, and chronic kidney disease (CKD).


Company Profile & Information (OTCQB:MRZM)

Showcase News Releases

Showcase news

P Squared Renewables Inc.
Universal Ibogaine Provides Update on Kelburn Recovery Center
Prospera Energy Inc
Prospera Energy Inc. Announces Milestone Q2 2022 Revenue (Increase of 860% over Q2 2021)
Saturn Oil & Gas Inc.
Saturn Oil & Gas Inc. Reports Q2 2022 Financial and Operational Results Highlighted by Record Quarterly Cash Flow

More Showcase News Releases »